|
|
Volumn 352, Issue 9141, 1998, Pages 1709-1710
|
|
β2 agonists and heart failure [10]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BAMBUTEROL;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
SALMETEROL;
BETA 2 ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
DRUG DERIVATIVE;
SALBUTAMOL;
TERBUTALINE;
DRUG SAFETY;
HEART FAILURE;
HUMAN;
LETTER;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
CHEMICALLY INDUCED DISORDER;
CONGESTIVE HEART FAILURE;
DRUG POTENTIATION;
EVIDENCE BASED MEDICINE;
METHODOLOGY;
NOTE;
POSTMARKETING SURVEILLANCE;
STANDARD;
ADRENERGIC BETA-AGONISTS;
ALBUTEROL;
EVIDENCE-BASED MEDICINE;
HEART FAILURE, CONGESTIVE;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
RECEPTORS, ADRENERGIC, BETA-2;
RESEARCH DESIGN;
TERBUTALINE;
|
|
EID: 0032556355
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)61488-2 Document Type: Letter |
|
Times cited : (8)
|
|
References (2)
|
